Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 Pathway

    Authors

    P. E. Kolattukudy;J. L. Niu

    Comments

    Authors: contact us about adding a copy of your work at [email protected]

    Abbreviated Journal Title

    Circ.Res.

    Keywords

    cardiovascular disease; type 2 diabetes; angiogenesis; adipogenesis; osteoclastogenesis; NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; ZINC-FINGER PROTEIN; TOLL-LIKE RECEPTORS; C-REACTIVE PROTEIN; EXPERIMENTAL; MYOCARDIAL-INFARCTION; CARDIAC-SPECIFIC EXPRESSION; INSULIN-RESISTANCE; TRANSCRIPTION FACTOR; CARDIOVASCULAR-DISEASE; Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular; Disease

    Abstract

    Numerous inflammatory cytokines have been implicated in the pathogenesis of cardiovascular diseases. Monocyte chemoattractant protein (MCP)-1/CCL2 is expressed by mainly inflammatory cells and stromal cells such as endothelial cells, and its expression is upregulated after proinflammatory stimuli and tissue injury. MCP-1 can function as a traditional chemotactic cytokine and also regulates gene transcription. The recently discovered novel zinc-finger protein, called MCPIP (MCP-1-induced protein), initiates a series of signaling events that causes oxidative and endoplasmic reticulum (ER) stress, leading to autophagy that can result in cell death or differentiation, depending on the cellular context. After a brief review of the basic processes involved in inflammation, ER stress, and autophagy, the recently elucidated role of MCP-1 and MCPIP in inflammatory diseases is reviewed. MCPIP was found to be able to control inflammatory response by inhibition of nuclear factor-kappa B activation through its deubiquitinase activity or by degradation of mRNA encoding a set of inflammatory cytokines through its RNase activity. The potential inclusion of such a novel deubiquitinase in the emerging anti-inflammatory strategies for the treatment of inflammation-related diseases such as cardiovascular diseases and type 2 diabetes is briefly discussed. (Circ Res. 2012;110:174-189.)

    Journal Title

    Circulation Research

    Volume

    110

    Issue/Number

    1

    Publication Date

    1-1-2012

    Document Type

    Review

    Language

    English

    First Page

    174

    Last Page

    189

    WOS Identifier

    WOS:000299023800020

    ISSN

    0009-7330

    Share

    COinS
     

    Accessibility Statement

    This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.